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Acute kidney injury (AKI) is a relatively common clinical condition, 
although the nature of AKI around the world is not well documented. 
Approximately 90% of published studies reporting the nature of AKI 
are from the developed world.[1] This literature suggests that severe 
AKI requiring renal replacement therapy is associated with high rates 
of in-hospital mortality.[2] Less severe degrees of kidney injury have 
also been associated with a significant increased risk of mortality, 
prolonged duration of hospital stay and associated costs.[3,4] AKI has 
also been clearly associated with long lasting health consequences 
for patients.[5] 
In contrast to the extensive literature on the nature and consequence 
of AKI in the developed world, there are scant studies focused upon 
AKI in sub-Saharan Africa (SSA). AKI is now highlighted as a ‘global 
health issue’, with a need for more accurate information on the 
burden of AKI to optimise strategies for prevention and lessening its 
impact globally. We have previously reported on the nature of AKI 
in Ethiopia, which focused on a population of patients admitted to 
a rural hospital through acute medical and surgical routes.[6] These 
data would suggest that there were differences in both the nature 
and impact of AKI in this SSA country compared with the studies 
mainly derived from the developed world. Our previous publication 
supports the assumption generated from the limited literature from 
the developing world that AKI in SSA is a disease of the young in 
whom pre-renal mechanisms predominate,[7,8] as a result of which 
overall mortality in the context of AKI may be lower.[9,10] Very little is 
known however regarding the nature of intrinsic renal disease and its 
association with AKI in this part of the world. 
In the current study we have characterised the nature of intrinsic 
renal disease resulting in AKI in the Sudan. We describe the 
demographics, histological diagnosis and clinical course of patients 
presenting to a single centre with AKI and active urinary sediment in 
whom native percutaneous renal biopsy was performed. 
Methods
This retrospective study of patients undergoing native renal biopsies 
from January 2005 until December 2014 was conducted in a single-
centre in Sudan to evaluate the pattern of intrinsic renal disease 
presenting as AKI. Percutaneous renal biopsy specimens were stained 
and analysed by light microscopy and immunohistochemistry (IgG, 
IgM, IgA and C3). For light microscopy, paraffin sections were 
routinely stained with periodic-acid Schiff stain, haematoxylin-
eosin, silver-methanamine and Congo red. Patients included in 
the analysis all presented with AKI defined by creatinine criteria 
associated with haematuria and RBCs cast or dysmorphic RBCs, 
and/or proteinuria of more than 1 g/d. No patients with suspected 
pre-renal AKI were included. The definition and recommendations 
provided by the kidney disease improving global outcomes (KDIGO) 
clinical guidlines for AKI, using creatinine (sCR) criteria were used 
for identification of AKI.[11] 
Baseline sCr values for patients were determined through review 
of all sCr values taken from the patient during the preceding 
12 months. For patients with unknown baseline values, sCr values 
charted after AKI resolution, were used to give an approximation 
of baseline sCr and confirmation of true AKI (this was applicable 
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to 14 patients). Hypertension at the time of AKI presentation was 
defined as any reading above or equal 140/90 on at least three 
successive occasions. Oliguria at presentation was defined as a 
urine output of less than 0.5 mL/kg/h for 6 hours. Patients were 
classified as having pre-existing chronic kidney disease (CKD) and 
therefore an episode of acute on chronic renal failure if the baseline 
eGFR (calculated by the abbreviated four variable MDRD equation) 
was <60 mL/min according to National Institute for Health and 
Clinical Excellence (NICE) CKD guidelines.[12] Recovery from AKI 
was defined as achievement of sCr no longer in keeping with the 
definition of AKI in comparison to baseline sCr values, or a return 
to within the normal range if baseline was not available. CKD was 
defined as residual renal impairment with persistent eGFR <60 but 
>15 mL/min. Dialysis outcome was defined as all patients with post 
AKI eGFR ≤15 mL/min. 
Statistical analysis was carried out using SPSS software, version 20 
(SPSS Inc., USA). The Student t-test was used for analysis of normally 
distributed data. Categorical data were compared using a Pearson 
χ2 test. p-values <0.05 were considered to represent statistically 
significant differences. 
Results
Patient characteristics
Data were collected on 100 consecutive patients with AKI who 
underwent diagnostic renal biopsy. Basic patient characteristics 
are shown in Table 1. The average age of the patients was younger 
than that generally published in series of patients with AKI in the 
developed world, with a slight preponderance of female patients. 
Baseline renal function was unavailable for 30 patients. For the 
remainder only 9 patients had evidence of pre-existing CKD defined 
as an eGFR <60 mL/min. 
Of those with baseline measurement of renal function (70 of 
100), almost half of the patients had AKI3, with the remainder 
equally distributed between AKI1 and AKI2. The most common 
clinical presentation was AKI associated with both haematuria 
and proteinuria (72/100), with the remaining patients presenting 
with isolated proteinuria (22/100) or haematuria (5/100). For the 
remaining patients, urinalysis was negative for both proteinuira 
and haematuria, but urine microscopy demonstrated the presence 
of granular casts. Of the total cohort, 65 patients were hypertensive 
at presentation, 41 of which presented with AKI, haematuria and 
proteinuria. In 33 patients AKI diagnosed by creatinine criteria was 
also accompanied by oliguia at presentation. 
Histological diagnosis
Histological diagnosis for all patients is shown in Table 2. The most 
common histological diagnosis in this series of patient with AKI 
was lupus nephritis (n = 31). For four of these patients there was 
no histological classification. Of the remaining patients, 1 staged as 
class 2 (mesangioproliferative), 4 as class 3 (focal sclerosis), 15 as 
class 4 (diffuse proliferative), 4 as class 5 (membranous) and 3 as 
class 6 (advanced sclerosing nephritis). For 25 of the AKI patients, 
the histological diagnosis was focal segmental glomerulosclerosis, 
one of which was associated with a diagnosis of leishmaniasis. For 
18 patients, the histological diagnosis was mesangioproliferative/
mesangiocapillary glomerulonephritis, of which one patient had 
evidence of associated schistosomiasis infection. Seven patients 
were diagnosed as post infectious glomerulonephritis, with all cases 
associated with a confirmed rise in ASO titres. Four patients were 
categorised as rapidly progressive (cresentic) glomerulonephritis, one 
Table 1. Patient characteristics at time of presentation* 
Age (years), mean (SD) 33.61 (14.1) 
Male/female, n 42:58
Baseline creatinine (mg/dL), mean (SD) 1.01 (0.5)
Baseline eGFR (mL/min), mean (SD) 91.5 (30.7)
Patients with CKD (eGFR ≤60 mL/min) 9 of 70 with baseline data
*Baseline data on renal function based either on sCr values taken from the patient during the 
preceding 12 months, or for patients with unknown baseline values, sCr values charted after 
AKI resolution were available for 70 of the 100 patients.
Table 2. Biochemical parameters, AKI stage and distribution of 
clinical syndromes at presentation of AKI*
Creatinine at presentation (mg/dL), 
mean (SD)
3.81 - 3.1 
Urea at presentation (mg/dL), 
mean (SD)
99.23 (54.00) 
Presenting with oliguria, n 33
AKI1, n (%) 18 (25.7)
AKI2, n (%) 19 (27.1)
AKI3, n (%) 33 (47.1)
With associated 
hypertension
Haematuria and proteinuria, n 72 41
Isolated proteinuria, n 22 13
Isolated haematuria, n 5 2
*AKI stage is provided for 70 of the 100 patients for whom baseline renal function was 
available.
Table 3. Distribution of histological diagnosis and number of 
patients treated with immunosuppression
Histological diagnosis Patients, n
Treated with 
immunosuppression, n 
Lupus nephritis (all classes) 31 27 
Focal segmental 
glomerulosclerosis
25 20 
Mesangiocapillary 
glomerulonephritis
18 13 
Post infections 
glomerulonephritis
7 4
RPGN/Cresentic 
glomerulonephritis
4 4 
IgA nephropathy 3 0
Membranous 
glomerulonephritis (non-
lupus related)
2 1
Mercury poisoning 1 0
Microscopic polyangiitis 1 0
Renal amyloidosis 1 1
Churg Strauss 1 1
HIV associated 
nephropathy
1 0
Non-specific glomerular 
changes
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of whom was antineutrophil cytoplasmic antibody (ANCA) positive 
and three who were antinuclear antibody (ANA) positive. 
Outcome
Data on the clinical outcome were available for 92 of the 100 patients. 
The mean (standard deviation (SD)) follow-up for this cohort was 
4.9 (5.7) months. There were five documented deaths among the 
whole cohort during the acute episode; no data were available on 
long-term mortality. For the group with follow-up data, 69 patients 
were given immunosuppressive treatment during the acute phase 
(predinisolone ± cyclophosphamide). In 47 patients, renal function 
returned to within the normal range (or back to the pre-AKI 
baseline value), and were classified as recovered. Thirty-one patients 
developed CKD following the AKI episode, while 14 patients 
remained dialysis dependent for the duration of the time for which 
follow-up data was available (Table 4). Recovery in the patients given 
immunosuppression (and for which outcome data was available) 
showed no statistical difference to that in the group given no specific 
therapy (38 of 69 v. 13 of 23, p=0.9). 
The group in which AKI lead to sustained residual renal impairment 
and CKD was significantly older than the group who recovered renal 
function to baseline (Table 5). While a higher baseline creatinine 
was statistically associated with the likelihood of having residual 
CKD following an episode of AKI, this relationship did not remain 
significant when baseline renal function was expressed as eGFR. As 
the calculation for eGFR takes account of age correction of renal 
function, this further supports the association of age with outcome 
rather than renal function per se. For those who remained dialysis 
dependent, the creatinine was higher than for the other two outcome 
groups at presentation of the AKI episode, suggesting that the degree 
of renal injury was the most important predictor of the likelihood of 
a patient becoming independent of renal replacement therapy. 
Discussion
AKI is increasingly prevalent in both developing and developed 
countries and is associated with severe morbidity and mortality. 
Across the world there are differences in epidemiology, clinical 
characteristics of AKI and availability of therapeutic options. 
The limited data generated from the developing world has, in 
the main, highlighted pre-renal aetiologies. In urban regions it is 
proposed that AKI is predominantly a hospital-acquired disease 
occurring mostly in older, critically ill multi-organ failure patients 
with substantial comorbidity. The main cause in this setting being 
sepsis, and is often associated with nephrotoxic drugs.[13] In rural 
areas it is proposed that AKI is usually community-acquired affecting 
younger and previously healthy individuals in which AKI is associated 
with diarrhoeal disease, infectious diseases, animal venoms, septic 
abortions, dyes and natural medicines.[14] Although there are a 
handful of studies describing the association between glomerular 
disease and CKD in Africa,[15-17] in contrast very little data exist on 
the nature of AKI. Specifically, to our knowledge, no studies have 
characterised glomerular disease in AKI in this geographical context. 
Our data demonstrate that glomerular disease presenting as 
AKI occurred in a young patient cohort, even accepting that the 
predicted life expectancy for this region is younger than that seen 
in the developed world.[18] This preponderance of younger patients 
is consistent with our previous published studies on AKI among 
acute hospital admissions in the neighbouring country of Ethiopia. [6] 
The data also demonstrate a preponderance of females (58%). 
Although consistent with data from South Africa (SA),[17] this is in 
contrast to the distribution of AKI in the developed world which 
predominantly occurs in elderly male populations.[19-21] The data also 
suggest that AKI associated with intrinsic renal disease/glomerular 
injury presents predominantly as AKI3. This is also in keeping with 
our previous data from Ethiopia in which 48% of patients presented 
with AKI3. This is in contrast to studies from the developed world in 
which milder stages of AKI predominate.[22,23] This may suggest that 
renal diseases in the developed world present to medical services at 
later stages, which may in part be related to a lack of appreciation of 
risk in this geographical setting.[24] This pattern of late presentation 
has also been seen in the context of CKD in SSA and is likely to reflect 
accessibility to healthcare services in the region.[17,25] It is also of note 
that in this study, we have only recruited from a cohort of patients 
with intrinsic renal disease and thus excluded patients with pre-renal 
AKI, which is also likely to contribute towards the predominance of 
Table 5. Factors influencing clinical outcomes
Recovery
Chronic renal 
impairment (years),
mean (SD) 
Dialysis 
dependency (years),
mean (SD) p-value
Age (years), mean (SD) 30.3 (10.1) 40.3 (16.9)* 30.3 (15.4) 0.005 
Creatinine at presentation  (mg/dL), mean (SD) 3.76 (3.1) 3.13 (1.7) 5.68 - 3.1† 0.009 
Baseline creatinine (mg/dL), mean (SD) 0.85 (0.2) 1.03 (0.3)‡ 1.76 (1.7) 0.02 
Baseline eGFR (mL/min), mean (SD) 98.0 (36.4) 75.6 (22.0) 81.3 (60.9) N/S
*Chronic renal impairment v. recovery.
† Dialysis v. recovery.
‡ Chronic renal impairment v. recovery.
Both baseline creatinine and baseline eGFR data are presented for 70 of the 100 patients for whom baseline renal function measurements were available. Recovery = sCr is no longer in keeping with 
the definition of AKI compared with baseline sCr values, or a return to within the normal range if baseline was not available. CKD = residual renal impairment with persistent eGFR <60 but  
>15 mL/min. Dialysis = defined as all post-AKI eGFR ≤15 mL/min).
Table 4. Outcome of renal function following AKI episode
Renal outcome Patients, n
Length of follow-up (mo), 
mean (SD) 
Recovery* 47 4.55 (6.10)
Chronic renal 
impairment†
31 5.19 (5.60) 
Dialysis dependency‡ 14 5.41 (4.20)
No data available 8
*Recovery = sCr is no longer in keeping with the definition of AKI in comparison with 
baseline sCr values, or a return to within the normal range if baseline was not available. 
† CKD = residual renal impairment with persistent eGFR <60 but >15 mL/min. 
‡ Dialysis is defined as all post-AKI eGFR ≤15 ml/min).
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AKI3. Similarly the exclusion of pre-renal causes of AKI accounts for 
the small number of patients with pre-existing CKD (eGFR ≤60 ml/
min) in this study. 
The pattern of glomerular disease presenting as AKI in this study, 
is also markedly different to that seen in developed countries, but is 
in keeping with studies describing the patterns of chronic glomerular 
disease in both the developing world and more specifically SSA. Previous 
studies from SA suggest that mesangiocapillary glomerulonephritis and 
focal and segmental glomerulosclerosis are among the most common 
forms of primary glomerulonephritidis. [17,26] This is also supported by a 
review of renal histological diagnosis of all renal biopsies reported over 
10 years ago from Sudan.[16] Our data supports the assumption that 
these are also the most common forms of primary glomerular diseases 
presenting as AKI. It is hypothesised that the differences in prevalence 
of glomerular diseases may be explained by the ‘hygiene hypothesis’. [27] 
By this hypothesis the overall hygiene and socioeconomic status 
of a country through exposure to microbes, may predispose its 
citizens to a Th1-dominant immunological response, which favours 
the development of glomerulonephritis such as mesangiocapillary 
glomerulonephritis. In contrast, other types of glomerulonephritis 
such as IgA nephropathy have a predominantly Th2 response, and 
better public hygiene and fewer infections observed in industrialised 
nations my lead to a persistence of the Th2 phenotype. Although 
we cannot completely rule out the possibility that this pattern of 
glomeulonephritis may not represent an ‘idiopathic’ diagnosis, in all but 
two patients there was no evidence to support secondary causes such as 
chronic bacterial and viral infections or autoimmune diseases. In the 
context of the high incidence of FSGS in this study, the identification 
of coding region variants in apolipoprotein L1 (APOL1), encoding 
apolipoprotein L1, may be of note. These variants are restricted to 
populations of recent African descent and are strongly associated with 
clinically diagnosed primary renal disease/FSGS/nephrosclerosis in the 
setting of hypertension.[28] Although the frequency of these variants 
may be lower in eastern African, to our knowledge there is no data on 
the frequency in Sudan. It is also of note that in the group of patients 
with FSGS in this study, only 50% were hypertensive at presentation, 
possibly suggesting that there is no association in this cohort, although 
accepting the small numbers affected. 
The high incidence of AKI caused by lupus nephritis in this series 
is also of note. The epidemiology of systemic lupus erythematosus 
in Africa is largely undetermined. The general view however has 
prevailed that the incidence of SLE in Africans is negligible.[27] This 
view has been driven by the rarity of autoimmune diseases in malaria-
endemic tropical areas has been ascribed to infection-induced 
immunosuppression.[29] Furthermore, an increased prevalence of 
SLE has been suggested within people of African descent when they 
are not living in Africa.[30] This has led to the assumption that on 
the African continent itself the incidence of SLE is low. It is likely 
that this view is in part due to the paucity of published studies and 
likely under-diagnosis resulting from poor access to healthcare. This 
view on the prevalence of lupus has recently been challenged with 
a questionnaire-based study across 13 African countries suggesting 
a much higher than previously anticipated rate of diagnosis.[30] 
This is also supported by a study from SA in which lupus nephritis 
represented the most frequent secondary glomerular disease in a 
retrospective review of biopsy proven renal disease.[17] Our data are 
therefore consistent with those latter observations and confirms 
lupus as a significant secondary cause of AKI. 
Finally, our study provides intriguing observations related to 
the acute outcome of AKI caused by intrinsic renal disease. In this 
patient cohort, peak creatinine as a measure of injury at presentation 
was associated with increased likelihood of remaining dialysis-
dependent, consistent with many published series of AKI.[3,31,32] 
In contrast to other studies however, oliguria was not associated 
with outcome. This may be a reflection of the studied group and 
the exclusion of pre-renal aetiologies in which oliguria may have 
greater significance. It is also of note that although a higher baseline 
creatinine was statistically associated with the likelihood of having 
residual CKD following an episode of AKI, this relationship did 
not remain significant when baseline renal function was expressed 
as eGFR as the main determinant of development of CKD was age 
at presentation. Clearly in many cases the underlying histological 
diagnosis represents a ‘chronic’ condition in which the lesions are 
not reversible, however how this acute episode impacts on the 
likelihood of developing progressive CKD is beyond the scope of 
this study as discussed below. It is also important to note the overall 
life expectancy in Sudan to place the age of these patients in context. 
Although providing useful data on the nature of AKI, our findings 
need to be qualified by the limitations of the study and the nature 
of that data that it was possible to collect. This was a single-centre 
study and its retrospective nature limited the type of data that we 
could collect. In particular we were unable to collect detailed clinical 
information regarding patient comorbidities and medication, nor 
information regarding the presenting episode (i.e. concurrent acute 
illnesses), which may have contributed to the onset of the AKI 
episode. In addition the duration of follow-up for the patients due 
to the nature of the organisation of healthcare did not allow us to 
evaluate the long-term impact of AKI on either renal function or 
patient mortality. As such we are unable to assess if there was any 
delayed improvement or progressive change in renal function for 
any of these patients. In addition due to the retrospective nature of 
the study we were unable to identify patients who required renal 
replacement therapy during the initial illness. Finally, due to the 
nature of the data storage systems used in the past decade, it is of 
note that we were unable to collect a complete data set for all patients. 
Accepting these limitations, this is the first study providing a broad 
account of biopsy-proven intrinsic renal disease causing AKI, and as 
such it will help to inform the global discussion regarding AKI. 
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